Abstract
Colitis other than ulcerative colitis or Crohn’s disease affects a large group of patients. Etiology is multifactorial and includes infection, hyperosmolar formula feeding, a lack of breast milk, ischemia and reperfusion injury, Clostridium difficile, and viral and parasitic agents. The main symptoms are diarrhea; leukocytosis; fever; abdominal pain or cramping; bloody, mucoid, green, foul-smelling stools; the urge to defecate; and others such as dehydration, electrolyte disturbances, nausea, vomiting, malaise, anorexia, hypoalbuminemia, and anasarca. Diagnostic procedures include laboratory studies, endoscopy, plain abdominal radiography, computed tomography, and histology. Therapy depends of the exact diagnosis and may include conservative treatment; antibiotics causing the condition should be stopped and the patient should be rehydrated and given metronidazole/vancomycin). Surgery is required in rare cases to treat infections that worsen or do not respond to conservative treatment, or when there are any complications. Various approaches can be used, including early subtotal colectomy, colectomy, colostomy, ileostomy, and resection of the diseased bowel.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Fagenholz PJ, de Moya MA. Acute inflammatory surgical disease. Surg Clin North Am. 2014;94(1):1–30. doi:10.1016/j.suc.2013.10.008.
Moldovan R, Vlad N, Curca G, Borcea M, Ferariu D, Dimofte G, Tarcoveanu E. Total necrotizing colitis proximal to obstructive left colon cancer: case report and literature review. Chirurgia (Bucur). 2013;108(3):396–9.
Bode L, Jantscher-Krenn E. Structure-function relationships of human milk oligosaccharides. Adv Nutr. 2012;3(3):383–91.
Sherid M, Ehrenpreis ED. Types of colitis based on histology. Dis Mon. 2011;57(9):457–89.
Andres LA, Ford RD, Wilcox RM. Necrotizing colitis caused by systemic aspergillosis in a burn patient. J Burn Care Res. 2007;28(6):918–21.
McDonald EG, Lee TC. Treatment for Clostridium difficile infection in adults. JAMA. 2015;313(19):1974–5.
Aldrete Sdel M, Magee MJ, Friedman-Moraco RJ, Chan AW, Banks GG, Burd EM, Kraft CS. Characteristics and antibiotic use associated with short-term risk of clostridium difficile infection among hospitalized patients. Am J Clin Pathol. 2015;143(6):895–900.
Bagdasarian N, Rao K, Malani PN. Diagnosis and treatment of Clostridium difficile in adults: a systematic review. JAMA. 2015;313(4):398–408.
Leffler DA, Lamont JT. Clostridium difficile infection. N Engl J Med. 2015;372(16):1539–48.
Farooq PD, Urrunaga NH, Tang DM, von Rosenvinge EC. Pseudomembranous colitis. Dis Mon. 2015;61(5):181–206.
Costello SP, Chung A, Andrews JM, Fraser RJ. Fecal microbiota transplant for Clostridium difficile colitis-induced toxic megacolon. Am J Gastroenterol. 2015;110(5):775–7.
Marcos LA, Gersh A, Blanchard K, Foil S, Mallini B, Farrell SE, Kahler RJ. Fecal transplantation to treat initial severe Clostridium difficile infection with sepsis. Miss State Med Assoc. 2015;56(2):38–40.
Cammarota G, Masucci L, Ianiro G, Bibbò S, Dinoi G, Costamagna G, Sanguinetti M, Gasbarrini A. Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infection. Aliment Pharmacol Ther. 2015;41(9):835–438.
FitzGerald JF, Hernandez Iii LO. Ischemic colitis. Clin Colon Rectal Surg. 2015;28(2):93–8.
Mosińska P, Fichna J. Ischemic colitis: current diagnosis and treatment. Curr Drug Targets. 2015;16(3):209–18.
Hines DM, McGuiness CB, Schlienger RG, Makin C. Incidence of ischemic colitis in treated, commercially insured hypertensive adults: a cohort study of US health claims data. Am J Cardiovasc Drugs. 2015;15(2):135–49.
Zollner-Schwetz I, Herzog KA, Feierl G, Leitner E, Schneditz G, Sprenger H, Prattes J, Petritsch W, Wenzl H, Kump P, Gorkiewicz G, Zechner E, Högenauer C. The toxin-producing Pathobiont Klebsiella oxytoca is not associated with flares of inflammatory bowel diseases. Dig Dis Sci. 2015;60:3393–8.
Horiki N, Furukawa K, Kitade T, Sakuno T, Katsurahara M, Harada T, Tano S, Yamada R, Hamada Y, Inoue H, Tanaka K, Gabazza EC, Ishii N, Fukuda K, Omata F, Fujita Y, Tachibana H, Takei Y. Endoscopic findings and lesion distribution in amebic colitis. J Infect Chemother. 2015;21(6):444–8.
Korman T. Diagnosis and management of Clostridium difficile infection. Semin Respir Crit Care Med. 2015;36(1):31–43.
Macaigne G. Microscopic colitis. Rev Prat. 2015;65(3):307–11.
Bouma G, Münch A. Microscopic colitis. Dig Dis. 2015;33(2):208–14.
Plastaras L, Vuitton L, Badet N, Koch S, Di Martino V, Delabrousse E. Acute colitis: differential diagnosis using multidetector CT. Clin Radiol. 2015;70(3):262–9.
Assa A, Vong L, Pinnell LJ, Avitzur N, Johnson-Henry KC, Sherman PM. Vitamin D deficiency promotes epithelial barrier dysfunction and intestinal inflammation. J Infect Dis. 2014;210(8):1296–305.
Langner C, Aust D, Ensari A, Villanacci V, Becheanu G, Miehlke S, Geboes K, Münch A, Working Group of Digestive Diseases of the European Society of Pathology (ESP), European Microscopic Colitis Group (EMCG). Histology of microscopic colitis-review with a practical approach for pathologists. Histopathology. 2015;66(5):613–26.
Ohlsson B. New insights and challenges in microscopic colitis. Ther Adv Gastroenterol. 2015;8(1):37–47.
Farrukh A, Mayberry JF. Microscopic colitis: a review. Colorectal Dis. 2014;16(12):957–64.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Dziki, A. (2017). Other Colitides. In: Herold, A., Lehur, PA., Matzel, K., O'Connell, P. (eds) Coloproctology. European Manual of Medicine. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-53210-2_18
Download citation
DOI: https://doi.org/10.1007/978-3-662-53210-2_18
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-53208-9
Online ISBN: 978-3-662-53210-2
eBook Packages: MedicineMedicine (R0)